Особенности липидемии в условиях пищевого стресса у женщин репродуктивного возраста с проявлениями функциональной гиперандрогении
Диссертация
Функциональная гиперандрогения, большую часть которой составляет синдром поликистозных яичников, является наиболее распространенной эндокринной патологией среди женщин репродуктивного возраста. Этиология этого синдрома неизвестна. До недавнего времени, это состояние рассматривалось только как умеренное репродуктивное нарушение, главными клиническими осложнениями которого были гирсутизм… Читать ещё >
Список литературы
- Григорян О.Р. Современные аспекты патогенеза инсулинрезистентности при синдроме поликистозных яичников и возможности ее коррекции у женщин с избыточной массой тела / О. Р. Григорян, М. Б. Анциферов // Проблемы репродукции. 2000. — № 3. — С. 11−16.
- Дворяшина И.В. Ожирение и метаболический ннсулинрезнстентный синдром при ишемической болезни сердца: Дис.. д-ра мед. наук / И. В. Дворяшина. — М., 2001.
- Демидова И.Ю. Метформин (Сиофор®-): механизм действия и клиническое применение / И. Ю. Демидова, Н. Г. Игнатова, И. М. Рейдис // Новости науки и техники. Сер. Медицина. Вып. Клин, эндокринология / ВИНИТИ. 1998. — № 1. -С. 3−27.
- Долгих В.Т. Патофизиология обмена веществ / В. Т. Долгих. М.: Мед. кн., 2002.- 152 с.
- Железнов Б.И. Спорные и неясные вопросы терминологии, морфологиии лечения склерокистозных яичников / Б. И. Железнов // Акушерство и гинекология. 1982. — № 2. — С. 10−16.
- Зыкова Т.А. Клинические и метаболические аспекты синдрома поликистозных яичников: Дис.. д-ра мед. наук / Т. А. Зыкова. М., 2001.
- Кирющенков А.П. Поликистозные яичннки / А. П. Кирющенков, М. Г. Совчи // Акушерство и гинекология. 1994. — № 1. — С. 11−14.
- Климов А.Н. Обмен липидов и липопротеидов и его нарушения / А. Н. Климов, Н. Г. Никульчева. СПб.: ПИТЕР, 1999. — 505 с.
- Ю.Ютиническая биохимия: Рук. по клин, диагностике / Под ред. М. А. Базарновой. — Киев: Высш. шк., 1990. 319 с.
- Н.Клинический и ферментативный методы диагностики алкоголизма: Метод, рекомендации / Под ред. И. Н. Пятницкой. М., 1984. — 23 с.
- Соколов Е.Н. Сахарный диабет и атеросклероз / Е. Н. Соколов. — М.: Наука, 1996.-404 с.
- Субботин Ю.К. О содержании понятий «признак», «симптом», «симптомокомплекс», «синдром» в языке медицины / Ю. К. Субботин // Вестн. АМН СССР. — 1977. № 4. — С. 42−48.
- Творогова М.Г. Обратный транспорт холестерина / М. Г. Творогова // Кардиология. 2001. — № 2. — С. 66−71.
- Хейфец С.Н. О некоторых дискуссионных аспектах проблемы склерокистозных яичников / С. Н. Хейфец // Акушерство и гинекология. 1982. — № 2. — С. 16−18.
- Щукина Г. Н. Толерантность к жировой нагрузке у больных ишемической болезнью сердца: Дис.. канд. мед. наук / Т. Н. Щукина. М., 1991.
- А survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile / E. Diamanti-Kandarakis, C.R. Kouli, A.T. Bergiele et al. // J. Clin. Endocrinol. Metab. 1999. — Vol. 84. — P. 4006−4011.
- Adams J. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism / J. Adams, D.D. Poison, S. Franks // Br. Med. J. 1986. — Vol. 293.-P. 355−359.
- Additive effects of growth hormones and testosterone on lipolysis in adipocytes of hypophysectomized rats / S. Yang, X. Xu, P. Bjorntorp, S. Eden // J. Endocr. — 1995. -Vol. 147.-P. 147−152.
- Adrenal function in normal women and women with the polycystic ovary syndrome / G.C.L. Lachelin, M. Barnett, B.H. Hopper et al. // J. Clin. Endocrinol. Metab. 1979. — Vol. 49. — P. 892−890.
- Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study / E. Talbott, A. Clerici, S.L. Berga et al. //J. Clin. Epidemiol. 1998. — Vol. 51, № 5. — P. 415−422.
- Altered composition of high density lipoproteins in women with the polycystic ovary syndrome / M. Rajkhowa, R.H. Neary, P. Kumpatia et al. // Clin. Endocrinol. Metab. 1997. — Vol. 82. — P. 3389−3394.
- Altered composition of high density lipoproteins in women with the polycystic ovary syndrome / M. Rajkhowa, R.H. Neary, P. Kumpatia et al. // J. Clin. Endocrinol. Metab. 1997. — Vol. 82, № 10. — P. 3389−3394.
- Amiel S.A. Imparied insulin action in puberty. A contributing factor to poor glycemie control in adolescents with diabetes / S.A. Amiel, R.S. Sherwin // N. Engl. J. Med. 1986.-Vol. 315.-P. 215−219.
- An overview of the diagnostic considerations in polycystic ovarian syndrome / W.F. Crowley, J.E. Hall, K.A. Martin et al. // Ann. N. Y. Acad. Sci. 1993. — Vol. 687. — P. 235−241.
- Azziz R. Nonclassic adrenal hyperplasia: Current concepts / R. Azziz, D. Dewailly, D. Owerbach // J. Clin Endocrinol Metab. 1994. — Vol. 78. — P. 810−817.
- Balen A.H. Polycystic ovary syndrome. The spectrum of the disorder in 1741 patients / A.H. Balen, G.S. Conway // Human Reprod. 1995. — Vol. 10. — P. 21 072 111.
- Birth weight, adult weight, and girth as predictors of the metabolic syndrome in postmenopausal women: the Rancho Bernardo Study / D.E. Yarbrough, E. Barrett-Connor, D. Kritz-Silverstein, D.L. Wingard // Diab. Care. 1998. — Vol. 21. — P. 1652−8.
- Burghen G.A. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease / G.A. Burghen, J.R. Givens, A.E. Kitabchi // J. Clin. Endocrinol. Metab. 1980. — Vol. 50. — P. 113−116.
- Cardiovascular risk in adolescent and young adult obese females with polycystic ovary syndrome (PCOS) / D. Macut, D. Micic, G. Cvijovic et al. // J. Pediatr. Endocrinol. Metab.-2001. -Vol.14, Suppl. 5.-P. 1353−1359.
- Carmina E. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? / E. Carmina, T. Koyama, L. Chang // Am. J. Obstet Gynecol. 1992. — Vol. 167. — P. 1807−1812.
- Carmina E. Polycystic ovaries in Hirsute women with normal menses / E. Carmina, R.A. Lobo // Am. J. Med. 2001. — Vol. 111, № 8. — P. 602−606.
- Cellular mechanisms of insulin resistance in polycystic ovarian syndrome / T. Ciaraldi, A. Roeiy, Z. Madar et al. // J. Clin. Endocrinol. Metab. 1992. — Vol. 75. -P. 577−583.
- Cohen J.C. Insulin resistance and diminished glucose tolerance in power lifters ingesting anabolic steroids / J.C. Cohen, R. Hickman // J. Clin. Endocr. Metab. — 1987. Vol. 64. — P. 960−971.
- Col. V. New insights into insulin resistance pathophysiology: how it affects glucose and lipid metabolism / V. Col // Rev. Assoc. Beige technol. Lab. 2002. -Vol. 29, № 1.-P. 9−19.
- Conway G.S. Polycicystic ovary syndrom: clinical aspects / G.S. Conway // Baillieres Clin. Endocrinol. Metab. 1966. — Vol. 10. — P. 263−280.
- Coronary heart disease risk factors in women with polycystic ovary syndrome / E. Talbott, D. Guzick, A. Clerici et al. // Arterioscler. Thromb. Vase. Biol. 1995. -Vol. 15, № 7.-P. 821−826.
- Dahlgren E. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women / E. Dahlgren // Acta Obstet Gynecol Scand.- 1992. Vol. 71. — P. 599−604.
- De Fronzo R.A. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dys lipidemia, and atherosclerotic cardiovascular disease / R.A. De Fronzo, E. Ferrannini // Diabetes Care. 1991. — Vol. 14. — P. 173 194.
- Dislipidaemia in polycystic ovarian syndrome: different groups, different aetiologies? / D. Meirow, I. Raz, O. Yossepowitch et al. // Hum Reprod. 1996. -Vol. 11, № 9.-P. 1848−1853.
- Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome? / T.L. Loucks, E.O. Talbott, K.P. McHugh et al. // Fertil. Steril. 2000. — Vol. 74, № 3. — P. 547−552.
- Dunaif A. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome / A. Dunaif, K.R. Segal // Diabetes. 1992. — Vol. 41. -P. 1257−1266.
- Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis / A. Dunaif // Endocr. Rev. 1997. — Vol. 18. — P. 774 800.
- Dunaif A. Insulin action in the polycystic ovary syndrome / A. Dunaif // Endocrinol. Metab. Clin. North. Am. 1999. — Vol. 28. — P. 341−359.
- Dunaif A. Current concepts in the polycystic ovary syndrome / A. Dunaif, A. Thomas // Annu. Rev. Med. 2001. — Vol. 52. — P. 401−419.
- Eden J.A. Which is the best way to detect the polycystic ovary? / J.A. Eden // Aust. N.Z. J. Obstet. Gynaecol. 1988. — Vol. 28. — P. 221−224.
- Effect of sex hormones on lipid peroxidation in women with polycystic ovary syndrome, healthy women, and men / Y. Dincer, E. Ozen, P. Kadioglu et al. // Endocr. Res.-2001.-Vol. 27, № 3.-P. 309−316.
- Effects of testosterone on muscle insulin sensitivity and morphology in female rats / A. Holmang, J. Svedberg, E. Jennische, P. Bjorntorp // Am. J. Physiol. 1990. -Vol. 258. — P. 555−560.
- Estrogen regulation of adipose tissue lipoprotein lipase-possible mechanism of body fat distribution / J.M. Price, S.N. O’Brien, B.H. Welter et al. // Amer. J. Obst. Gyn.-1998.-Vol. 178.-P. 101−107.
- Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome / R.S. Legro, D. Driscoll, J.F. Strauss et al. // Proc. Natl. Acad. Sci. USA. 1998. -Vol. 95.-P. 14 956−14 960.
- Evidence for a single gene defect causing polycystic ovaries and male pattern baldness / A.M. Carey, K.L. Chan, D. Short et al. // Clin. Endocrinol. 1993. — Vol. 38.-P. 653−658.
- Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone / A. Lanzone, M. Guido, M. Ciampelli et al. // Clin Endocrinol (Oxf). 1996. — Vol. 45, № 1. — P. 73−77.
- Exogenous androgens influence on body composition and regional body fat distribution in obese menopausal women. A clinical research center study / J.C. Lovejoy, G.A. Bray, M.O. Bourgeois et al. // J. Clin. Endocr. Metab. 1996. — Vol. 81.-P. 189−203.
- Famili-al hyperthecosis: Comparison of endocrinologic and histologic findings with polycystic ovarian disease / H.L. Judd, R.E. Scully, A.L. Herbs et al. // Am. J. Obstet. Gynecol. 1973. — Vol. 117. — P. 976−990.
- Ferriman D. Clinical assessment of body hair growth in women / D. Ferriman, J.D. Gallwey // J. Clin. Endocrinol. Metab. 1961. — Vol. 21. — P. 1440−1447.
- Ferriman D. The inheritance of polycystic ovarian disease and a possible relationship to premature balding / D. Ferriman, A. Punue // Clin. Endocrinol. 1979. -Vol. 11. — № 3. — P. 291−300.
- Franks S. Polycystic ovary syndrom / S. Franks // N. Engl. J. Med. — 1995. Vol. 333.-P. 853−861.
- Goldzieher J.W. The polycystic ovary: I. Clinical and histologic features / J.W. Goldzieher, A. Green // J. Clin. Endocrinol. Metab. 1962. — Vol. 22. — P. 325−335.
- Holmang A. The effects oftestosterone on insulin sensitivity in male rats / A. Holmang, P. Bjorntorp // Acta. Physiol. Scand. 1992. — Vol. 146. — P. 505−510.
- Holte J. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome / J. Holte, T. Bergh, C. Beme // J. Clin. Endocrinol. Metab. 1995. — Vol. 80. — P. 25 862 593.
- Huber L.A. 17-beta-estradiol inhibits LDL oxidation and cholesterol ester formation in cultured macrophages / L.A. Huber, E. Scheffler, T. Poll // Free Radic. Res. Commun. 1990. — № 8. — P. 167−73.
- Hull M.G. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies / M.G. Hull // Gynaecol. Endocrinol. — 1987.-№ l.-P. 235−245.
- Hypersecretion of an-drostenedione by isolated thecal cells from polycystic ovaries / C. Gilling-Smith, D.S. Willis, R.W. Beard, S. Franks // J. Clin. Endocrinol. ' Metab. 1994. — Vol. 79. — P. 1158−65.
- Karpe F. Postprandial lipoprotein metabolism and atherosclerosis / F. Karpe, A. Hamsten // Curr. Opin. Lipidol. 1995. -№ 6. — P. 123−129.
- Kumagai S. The effects ofestrogen and progesterone on insulin sensitivity in female rats / S. Kumagai, A. Holmang, P. Bjorntorp // Acta. Physiol. Scand. 1993. -Vol. 149.-P. 91−97.
- Landolt A. Pathology and natural course of prolactinomas / A. Landolt // Trends in diagnosis and treatment of pituitary adenomas. Amsterdam: Free University Press, 1984.-P. 91−102.
- Legro R.S. A fastinf glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic Ovary syndrome / R.S. Legro, D. Finegood, A. Dunaif// J. Clin. Endocrinol. Metab. 1998. — Vol. 83. — P. 2694−2698.
- Legro R.S. Polycystic ovary syndrome: Current and future treatment paradigms / R.S. Legro//Am. J. Obstet. Gynecol. 1998. — Vol. 179.-P. S101-S108.
- Legro R.S. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome / R.S. Legro, A.R. Kunselman, A. Dunaif// Am. J. Med. 2001. — Vol. Ill, № 8.-P. 607−613.
- Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters / LR. Pirwany, R. Fleming, I.A. Greer et al. // Clin. Endocrinol. (Oxf). 2001. — Vol. 54, № 4. — P. 447−453.
- Lipoprotein lipids in androgen excess—a study among Indian women / A. Maitra, P.K. Meherji, M.P. Desai et al. // Int. J. Fertil. Menopausal Stud. 1994. — Vol. 39, № 4.-P. 218−222.
- Lipoprotein lipids in women with androgen excess: independent associations with increased insulin and androgen / R.A. Wild, D. Applebaum-Bowden, L.M. Demers et al. // Clin. Chem. 1990. — Vol. 36, № 2. — P. 283−289.
- Lobo R.A. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome / R.A. Lobo, U. Goebelsmann, R. Horton // J. Din. Endocrinol. Metab. 1983. — Vol. 57. — P. 393 397.
- Lobo R.A. Plasma lipids and desogestrel and ethinyl estradiol: A meta-analysis / R.A. Lobo // Fertil Steril. 1996. — Vol. 65. — P. 1100−1111.
- Lobo R.A. The importance of diagnosing the polycystic ovary syndrome / R.A. Lobo, E. Carmina // Ann. Intern. Med. 2000. — Vol. 132,№ 12. — P. 989−993.
- Lustig R.H. Autonomic dysfunctin of the |3-cell and pathonesis of obesity / R.H. Lustig // Rev. Endocr. And Metab. Disorders. 2003. — Vol. 4, № I. — P. 23−32.
- Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment / J. Rincon, A. Holmang, E. Odegaard-Wahlstrom et al. // Diabetes. 1996. — Vol. 45. — P. 615−621.
- Mueller W.H. The changes with age of anatomical distribution of fat / W.H. Mueller//Soc. Sci. Med. 1982. — Vol. 16.-P. 191−196.
- Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone / J. Adams, S. Franks, D.W. Poison et al. // Lancet. 1985.-Vol. 11.-P. 1375−1378.
- Nestler J.E. A direct effect of hyperinsulinemia on serum sex hormon binding globulin levels in obese women with the polycystic ovary syndrome / J.E. Nestler, L.P. Powers // J. Clin. Endocrinol. Metab. 1991. — Vol. 72. — P. 83−89.
- Nestler J.E. Effects of insulin on steroidogenesis in vivo / J.E. Nestler, J.N. Clore, W.C. Blackard // Polycystic ovary syndrome. Boston: Blackwell scientific publications, 1992.
- Nestler J.E. Editorial. Sex hormon-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? / J.E. Nestler // J. Clin. Endocrinol. Metab. 1993. — Vol. 76. — P. 273−274.
- Nestler J.E. Role of hyperinsulinemia in the patogenesis of the polycystic ovary syndrome and its clinical implications / J.E. Nestler // Sem. Reprod. Endocrinol. -1997.-Vol. 15, № 2.-P. 111−122.
- Notle J. Restored insulin sensitivity but persistenly increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome / J. Notle, T. Bergh 11 Clin. Endocrinol. Metab. 1995. — Vol. 80. — P. 2586−2593.
- Plasma lipids, lipoproteins and apolipoproteins in hirsute women / C. Castelo-Branco, E. Casals, M.J. Martinez de Osaba et al. // Acta Obstet. Gynecol. Scand. — 1996. Vol. 75, № 3. — P. 261−265.
- PoIderman K.H. Induction of insulin resistance by androgens and estrogens / K.H. Polderman, L.J.G. Gooren, H. Ascheman // J. Clin. Endocr. Metab. 1994. — Vol. 79. -P. 265−271.
- Polycystic ovaries—a common finding in normal women / D.W. Poison, J. Adams, J. Wadsworth, S. Franks // Lancet. 1988. — № 1. — P. 870−872.
- Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect / L. lbanez, C. Vails, N. Potau et al. // Clin. Endocrinol. (Oxf). -2001. Vol. 55, № 5. — P. 667−672.
- Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause / J. Haarbo, U. Marslew, A. Gottfredsen, C. Christiansen // Metabolism. 1991. — Vol. 40. — P. 323−326.
- Postprandial triglyceride response in patients with polycystic ovary syndrome: relationship with waist-to-hip ratio and insulin / M.E. Velazquez, G.A. Bellabarba, S. Mendoza, L. Sanchez // Fertil. Steril. 2000. — Vol. 74, № 6. — P. 1159−1163.
- Postreceptor ebents involved in the up-regulation of P-adrenergic receptor mediated lipolysis by testosterone in rat white adipocytes / X. Xu, G. De Pergola, P. Erikssonetal. //Endocrinology. 1993.-Vol. 132.-P. 1651−1657.
- Premature balding, the male phenotype of polycystic ovaries / J. Stephens, A.H. Carey, F. Short et al. // J. Endocrinol. 1993. — Vol. 139. — P. 31−37.
- Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group / L. Farah, A J. Lazenby, L.R. Boots, R. Azziz // J. Reprod. Med. 1999. -Vol. 44. — P. 870−874.
- Rebuffe-Scrive M. Effect of testosterone on abdominal adipose tissue in men / M. Rebuffe-Scrive, P. Marin, P. Bjorntorp // Int. J. Obes. 1991. — Vol. 15. — P. 791 795.
- Regional adipose tissue metabolism in men and postmenopausal women / M. Rebuffe-Scrive, P. Lonnroth, P. Marin P. et al. // Int. J. Obes. 1987. — Vol. 11. — P. 347−355.
- Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state / J.R. Patsch, G. Miesenbock, T. Hopferwieser et al. // Arterioscler. Thromb. 1992. — Vol. 12.-P. 1336−1345.
- Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome /G.S. Conway, R. Agrawal, D.J. Betteridge, H.S. Jacobs // Clin. Endocrinol. 1992. — Vol. 37. — P. 119−125.
- Romero G. The involvment of inositol Phosphtoglycan mediators in the modulation of steroidogenesis by insulin and insulin-like growth factor-1 / G. Romero, J.C. Carmey, J.D. Veldhuis // Endocr. 1993. — Vol. 132. — P. 1561−1568.
- Sampson M. Ambulatory blood pressure profiles and plasminogen activator inhibitor (PA-1) activity in lean women with and without the polycystic ovarysyndrome / M. Sampson, С. Kong // Clin. Endocrinol. Oxf. 1996. — Vol. 45. — P. 623−629.
- Scott J. New chapter for the fat controller / J. Scott // Nature. 1996. — Vol. 379.-P. 113−114.
- Sjogren J. Androgen hormone binding to adipose tissue in rats / J. Sjogren, M. Li, P. Bjomtorp //Biochem. Biophys. Acta. 1995. — Vol. 1244. -P. 117−120.
- Smaller LDL particle size in women with polycystic ovary syndrome compared to controls / S. Dejager, C. Pichard, P. Giral et al. // Clin. Endocrinol. (Oxf). 2001. — Vol. 54, № 4. — P. 455−462.
- Steroid hormone receptors in human adipose tissue / M. Rebuffe-Scrive, M. Bronnegard, A. Nilsson et al. // J. Clin. Endocr. Metab. 1990. — Vol. 71. — P. 12 151 219.
- Strowitzki T. Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome / T. Strowitzki, B. Halser, T. Demant // Gynecol. Endocrinol. 2002. — Vol. 16, № 1. — P. 45−51.
- Tablott E. Coronary heart disease risk factors in women with polycystic ovary syndrome / E. Tablott, D. Guzick // After Throm. Vas. Biol. 1995. — Vol. 15. — P. 821−826.
- Tai M.M. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves / M.M. Tai // Diab. Care. 1994. — Vol. 17.-P. 152−154.
- Taylor A.E. Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implication / A.E. Taylor // Am. J. Obstet. Gynecol. 1998.-Vol. 170.-P. S94-S100.
- Testosterone treatment ofovarieectomized rats: effects on lipolysis regulation in adipocytes / G. De Pergola, A. Holmang, J. Svedberg et al. // Acta. Endocr. 1990. -Vol. 123.-P. 61−66.
- The adrenal hyperplasias / M.I. New, P.C. White, S. Pang et al. // The Metabolic Basis of Inherited Disease. New York: McGraw Hill, 1989. — P. 18 811 917.
- The effects oftestosterone treatment on body composition and metabolism in middle-aged men / P. Marin, S. Holmang, L. Jonsson et al. // Int. J. Obes. 1992. — Vol. 16.-P. 991−997.
- The long term health consequences of polycystic ovary syndrome / С.J. Kelly, J.M. Connell, I.T. Cameron et al. // В JOG. 2000. — Vol. 107, № 11. — P. 1327−38.
- The outcome ofin-vitro fertilization treatment in women with sono-graphic evidence of polycystic ovarian morphology I L. Engmann, N. Maconochie, P. Sladkevicius et al. // Hum. Reprod. 1999. — Vol. 14. — P. 167−171.
- Thompson P.D. Contrasting effects of testosteron and stanozolol on serum lipoprotein levels / P.D. Thompson, E.M. Cullinane, S.P. Sady // JZMZ. 1989. -Vol. 261.-P. 1165−1168.
- Tonetti D.A. Targeted anti-estrogens to treat and prevent diseases in women / D.A. Tonetti, V.C. Jordan // Mol. Med. Today. 1996. — Vol. 2, № 5. — P. 218−223.
- Vague J. The degree of masculine differentiation of obesities: a factor detrmining predisposition to diabetes, atherosclerosis, gout and uric calculous disease / J. Vague // Am. J. Clin. Nutr. 1956. — Vol. 4. — P. 20−34.
- Waterworth D.M. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome / D.M. Waterworth, S.T. Benett // Lancet. 1997. — Vol. 349. — P. 986−990.
- Wild R. A. The influence of body weigth on lipoprotein lipids on patients with polycystic ovaiy syndrome / R.A. Wild, M.J. Bartholomew // Am. J. Obstet. Ginecol. 1988.-Vol. 159.-P. 423−427.
- Wild R.A. Evidence of heterogeneous mechanisms in lipoprotein lipid alterations in hyperandrogenic women / R.A. Wild, N. Bartholomew, D. Applebaum-Bowden // Am. J. Obstet Gymecol. 1990. — Vol. 163. — P. 1998−2005.
- Wild R.A. Lipid and apolipoprotein abnormalities in hirsute women / R.A. Wild, P. Alaupovic, I.J. Parcer // Am. J. Obstet. Gynecol. 1992. — Vol. 166, № 4. -P. 1191−1196.
- Wild R.A. Obesity, lipids, cardiovascular risk, and androgen excess / R.A. Wild // Am. J. Med. 1995. — Vol. 98. — P. 27.
- Wild R.A. The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome / R.A. Wild II Am. J. Obstet. Gynecol. 1998. — Vol. 159.-P. 423−430.
- Women with polycystic ovary syndrome wedge resected in 1956−65. A long-term follow-up focusing on natural history and circulating hormones / E. Dahlgren, S. Johansson, G. Lindstedt et al. // Fertil. Steril. 1992. — Vol. 57. — P. 505−513.
- Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency / S.Y. Pang, M.A. Wallace, L. Hofman et al. // Pediatrics. 1988. — Vol. 81. — P. 866−874.
- Xu X. The effects ofandrogens on the regulation of lipolysis in adipose precursor cells / X. Xu, G. De Pergola, P. Bjorntorp // Endocrinology. — 1990. — Vol. 126.-P. 1229−1234.
- Yen S.S.C. Interface between extra-and intraovarian factors in polycystic ovarian syndrome / S.S.C. Yen, G.A. Laughlin, A.J. Morales // Ann. NY Acad. Sci. -1993.-Vol. 687.-P. 98−111.
- Zawadski J.K. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach / J.K. Zawadski, A. Dunaif // Polycystic ovaiy syndrome. Boston: Blackwell scientific publications, 1992. — P. 377−385.